sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Asia Pacific Vaccines Market Scope And Analysis

  • Report Code : TIPRE00005749
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 152
Buy Now

Asia Pacific Vaccines Market Analysis Report 2019 to 2027

Buy Now

Asia Pacific Vaccines Market Report Asia Pacific Vaccines Market Size and Share Asia Pacific Vaccines Market Scope and Analysis

Asia Pacific Vaccines Market Report Scope

Report Attribute Details
Market size in 2018 US$ 7,254.5 Million
Market Size by 2027 US$ 12,631.4 Million
Global CAGR (2019 - 2027) 6.4%
Historical Data 2016-2017
Forecast period 2019-2027
Segments Covered By Technology
  • Recombinant Vaccines
  • Conjugate Vaccines
  • Live Attenuated Vaccines
  • Inactivated and Subunit Vaccines
  • Toxoid Vaccines
By Disease Indication
  • DTP
  • Influenza
  • Hepatitis
  • Respiratory Syncytial Virus
By Route of Administration
  • Oral
  • Injectable
  • Other Routes of Administration
By Patient Type
  • Pediatric Patients
  • Adult Patients
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • PFIZER INC
  • GlaxoSmithKline plc
  • Merck Co Inc
  • Sanofi
  • Johnson Johnson Services Inc
  • Panacea Biotec Limited
  • Astellas Pharma Inc
  • NOVAVAX INC
  • VBI Vaccines Inc